Litcius/Paper detail

lncRNA <i>TUG1</i> as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases

Habib Haybar, Narjes Sadat Sadati, Daryush Purrahman, Mohammad‐Reza Mahmoudian‐Sani, Najmaldin Saki

2023Epigenomics13 citationsDOI

Abstract

Globally, cardiovascular diseases (CVDs) are among the leading causes of death. In light of the high prevalence and mortality of CVDs, it is imperative to understand the molecules involved in CVD pathogenesis and the signaling pathways that they initiate. This may facilitate the development of more precise and expedient diagnostic techniques, the identification of more effective prognostic molecules and the identification of potential therapeutic targets. Numerous studies have examined the role of lncRNAs, such as TUG1, in CVD pathogenesis in recent years. According to this review article, TUG1 can be considered a biomarker for predicting the prognosis of CVD.

Topics & Concepts

BiomarkerIdentification (biology)PathogenesisBiologyDiseaseComputational biologyBioinformaticsCause of deathDiagnostic biomarkerMolecular biomarkersMedicineInternal medicineImmunologyGeneticsBotanyCancer-related molecular mechanisms researchRNA regulation and diseaseInflammasome and immune disorders
lncRNA <i>TUG1</i> as Potential Novel Biomarker for Prognosis of Cardiovascular Diseases | Litcius